Ludwig-Maximilians-Universität (LMU)

Digital health transition in rheumatology: A qualitative study (2021) Müehlensiepen F, Kurkowski S, Krusche M, Mucke J, Prill R, Heinze M, Welcker M, et al. Journal article Considering the Environmental Impacts of BioenergyTechnologies to Support German Energy Transition (2021) Kalu A, Vrzel J, Kolb S, Karl J, Marzahn P, Pfaffenberger F, Ludwig R Journal article Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling (2021) Alesutan I, Luong TT, Schelski N, Masyout J, Hille S, Schneider M, Graham D, et al. Journal article Femtosecond Laser Induced Resonant Tunneling in an Individual Quantum Dot Attached to a Nanotip (2021) Duchet M, Perisanu S, Purcell ST, Constant E, Loriot V, Yanagisawa H, Kling MF, et al. Journal article Correlation of mesolevel characteristics of the healthcare system and socioeconomic inequality in healthcare use: A scoping review protocol (2021) Novelli A, Schuettig W, Spallek J, Wachtler B, Diehl K, Moor I, Richter M, et al. Journal article, Review article Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women (2021) Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, et al. Journal article Dermatological Quality of Life and Neurodermatitis: Results from the German Neurodermatitis Registry TREATgermany (2021) Helmert C, Haufe E, Abraham S, Heratizadeh A, Harder I, Kleinheinz A, Wollenberg A, et al. Conference contribution Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial (2021) Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. Conference contribution High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE (2021) Harbeck N, Johnston S, Fasching P, Martin M, Toi M, Rastogi P, Song C, et al. Conference contribution